drugset / Trial / NCT00452725
Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome
Non-randomizedSingle-groupOpen-labelTreatment
Summary
1. Clinical Objective : To improve the growth of these children 2. Genetic objective : A study of the genetics of the syndrome
Timeline
- Start
- 1997-10
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MAXOMAT | Protein / enzyme biologic | — | — |